Collegium Pharmaceutical (COLL) Assets Average (2015 - 2026)

Collegium Pharmaceutical has reported Assets Average for 12 years, with the latest figure at $1.9 billion in Q2 2026.

• On a quarterly basis, Assets Average rose 17.49% year-over-year to $1.9 billion in Q2 2026; TTM through Jun 2026 was $1.9 billion, a 17.49% increase from a year earlier, with the FY2025 full-year figure at $1.7 billion, up 18.3% from the prior year.
• Assets Average was $1.9 billion for Q2 2026 at Collegium Pharmaceutical, up from $1.7 billion in the prior quarter.
• The five-year high for Assets Average was $1.9 billion in Q2 2026, with the low at $969.1 million in Q1 2022.
• Average Assets Average over 5 years is $1.4 billion, with a median of $1.2 billion recorded in 2022.
• The sharpest annual moves came in 2022 and 2024: Assets Average soared 83.24% in 2022, then decreased 10.73% in 2024.
• Over 5 years, Assets Average stood at $1.2 billion in 2022, then fell by 2.28% to $1.2 billion in 2023, then surged by 42.13% to $1.6 billion in 2024, then decreased by 1.05% to $1.6 billion in 2025, then rose by 16.04% to $1.9 billion in 2026.
• The last three Assets Average figures came in at $1.9 billion (Q2 2026), $1.7 billion (Q1 2026), and $1.6 billion (Q4 2025), per Business Quant data.